Neuropace Inc
Change company Symbol lookup
Select an option...
NPCE Neuropace Inc
CO Global Cord Blood Corp
AHT-G Ashford Hospitality Trust Inc
LUVU Luvu Brands Inc
MYD BlackRock MuniYield
NMG Nouveau Monde Graphite Inc
VLYPO Valley National Bancorp
PEPL PepperLime Health Acquisition Corp
GAINN Gladstone Investment Corp
SUPN Supernus Pharmaceuticals Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

Closing Price
$3.75
Day's Change
0.25 (7.14%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.83
Day's Low
3.44
Volume
(Heavy Day)
Volume:
75,703

10-day average volume:
26,964
75,703

There is no peer information for NPCE.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.